Patricia L. Myskowski

Author

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

P L Myskowski, P Myskowski, P. L. Myskowski, P. Myskowski, P.L. Myskowski, PATRICIA L. MYSKOWSKI, Patricia L Myskowski, Patricia L. Myskowski, Patricia Myskowski, Patricia. L. Myskowski

234

Publications

7.7K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cornell University The University of Texas MD Anderson Cancer Center Dana-Farber Cancer Institute Washington University in St. Louis

About

Patricia L. Myskowski is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, pathology, and dermatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	40	2K
2	Immunology	15	18	1K
3	Health Sciences	3	3	102
4	Engineering	1	1	53
5	Allergy	1	1	64

Patricia L. Myskowski

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
Bexarotene Is Effective and Safe for Treatment of Refractory Advanced-Stage Cutaneous T-Cell Lymphoma: Multinational Phase II-III Trial Results Madeleine Duvic, Kenneth B. Hymes, Peter Heald, Journal of Clinical Oncology	2001	701
Preliminary Observations on the Effect of Recombinant Leukocyte a Interferon in Homosexual Men with Kaposi's Sarcoma Susan E. Krown, Francisco X. Real, Susanna Cunningham–Rundles, New England Journal of Medicine ImmunodeficienciesImmunologyPathologyHepatitis B VirusImmunotherapy	1983	358
Randomized Double-Blind Trial of Prophylactic Oral Minocycline and Topical Tazarotene for Cetuximab-Associated Acne-Like Eruption Alon Scope, Anna Liza C. Agero, Stephen W. Dusza, Journal of Clinical Oncology	2007	275
Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma Steven M. Horwitz, Raphael Koch, Pierluigi Porcu, Blood	2017	274
Molluscum contagiosum in patients with human immunodeficiency virus infection Joseph J. Schwartz, Patricia L. Myskowski Journal of the American Academy of Dermatology MicrobiologyInfection ControlHivClinical Infectious DiseaseMedicine	1992	216
Analysis of Dermatologic Events in Vemurafenib-Treated Patients With Melanoma Mario E. Lacouture, Madeleine Duvic, Axel Hauschild, The Oncologist	2013	213
Pulmonary Kaposi's sarcoma in the acquired immune deficiency syndrome Gianfranco U. Meduri, Diane E. Stover, Marjorie Lee, The American Journal of Medicine Primary ImmunodeficiencyPulmonary PathologyAutoimmune DiseaseImmunologyPulmonary Kaposi	1986	189
A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas Alison J. Moskowitz, Paola Ghione, Eric D. Jacobsen, Blood	2021	159
Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma Youn H. Kim, Francine Foss, Jasmine Zain, Blood	2012	130
Outbreak of Kaposi's sarcoma with cytomegalovirus infection in young homosexual men Carlos Urmacher, Patricia L. Myskowski, M. Ochoa, The American Journal of Medicine Young Homosexual MenCytomegalovirus InfectionPathology	1982	124

Page 1